Home
Live Updates
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript : vimarsana.com
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2023.
Related Keywords
Saudi Arabia ,
West Virginia ,
United States ,
Canada ,
San Diego ,
California ,
Bahrain ,
Australia ,
United Kingdom ,
Massachusetts ,
France ,
Maine ,
Washington ,
Switzerland ,
Tennessee ,
Oklahoma ,
Missouri ,
Kingdom Of Saudi Arabia ,
Great Britain ,
French ,
Stuart Arbuckle ,
Evan Seigerman ,
Phil Nadeau ,
Robyn Karnauskas ,
Geoff Meacham ,
Susie Lisa ,
Jessica Fye ,
Salveen Richter ,
America Merrill Lynch ,
Chris Raymond Piper Sandler ,
Mohit Bansal ,
Myles Minter William Blair ,
Piper Sandler ,
Jessica Fye Jpmorgan ,
William Blair ,
Salveen Richter Goldman Sachs ,
Myles Minter ,
Robyn Karnauskas Truist ,
Reshma Kewalramani ,
Charlie Wagner ,
Colin Bristow ,
Chris Raymond ,
Company Analyst ,
Geoff Meacham Bank ,
Pivotal Development Program ,
Exchange Commission ,
French National Authority For Health ,
Goldman Sachs ,
Vertex Pharmaceuticals ,
Wells Fargo ,
Vice President ,
Motley Fool Stock Advisor ,
Stock Advisor ,
Chief Executive ,
North America ,
Vertex San Diego ,
French National Authority ,
Middle East ,
Prevent Addiction ,
Nation Act ,
Non Opioids Prevent Addiction ,
Fargo Securities ,
Wells Fargo Securities ,
Hief Executive Officer ,
Ourth Quarter ,
Ickle Cell Disease ,
Eta Thalassemia ,
vimarsana.com © 2020. All Rights Reserved.